These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 9784278)
21. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene. Lee Y; Su M; Messing A; Brenner M Glia; 2006 May; 53(7):677-87. PubMed ID: 16482522 [TBL] [Abstract][Full Text] [Related]
22. Effect of astrocyte-targeted production of IL-6 on traumatic brain injury and its impact on the cortical transcriptome. Quintana A; Molinero A; Borup R; Nielsen FC; Campbell IL; Penkowa M; Hidalgo J Dev Neurobiol; 2008 Feb; 68(2):195-208. PubMed ID: 18000830 [TBL] [Abstract][Full Text] [Related]
23. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions. Sousa Vde O; Romão L; Neto VM; Gomes FC Eur J Neurosci; 2004 Apr; 19(7):1721-30. PubMed ID: 15078546 [TBL] [Abstract][Full Text] [Related]
24. Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice. Penkowa M; Giralt M; Moos T; Thomsen PS; Hernández J; Hidalgo J Exp Neurol; 1999 Mar; 156(1):149-64. PubMed ID: 10192786 [TBL] [Abstract][Full Text] [Related]
25. GFAP promoter elements required for region-specific and astrocyte-specific expression. Lee Y; Messing A; Su M; Brenner M Glia; 2008 Apr; 56(5):481-93. PubMed ID: 18240313 [TBL] [Abstract][Full Text] [Related]
26. Metallothionein isoforms (I+II and III) and interleukin-6 in the hippocampus of old rats: may their concomitant increments lead to neurodegeneration? Mocchegiani E; Giacconi R; Fattoretti P; Casoli T; Cipriano C; Muti E; Malavolta M; DiStefano G; Bertoni-Freddari C Brain Res Bull; 2004 Mar; 63(2):133-42. PubMed ID: 15130702 [TBL] [Abstract][Full Text] [Related]
27. Transgenic mice expressing polyoma virus large T antigen in astrocytes develop severe dysmyelination of the central nervous system. Baron-Van Evercooren A; Jensen NA; Wyss MT; Cuzin F; Rassoulzadegan M; Brucher JM; Baron H Lab Invest; 1992 Jan; 66(1):39-53. PubMed ID: 1309929 [TBL] [Abstract][Full Text] [Related]
28. Differential expression of the metallothionein gene in liver and brain of mice and rats. Choudhuri S; McKim JM; Klaassen CD Toxicol Appl Pharmacol; 1993 Mar; 119(1):1-10. PubMed ID: 8470112 [TBL] [Abstract][Full Text] [Related]
29. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging. Su W; Xing R; Guha A; Gutmann DH; Sherman LS Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023 [TBL] [Abstract][Full Text] [Related]
30. Molecular cloning and expression of the canine metallothionein-III gene. Kojima S; Shimada A; Kodan A; Kobayashi K; Morita T; Yamano Y; Umemura T Can J Vet Res; 1998 Apr; 62(2):148-51. PubMed ID: 9553716 [TBL] [Abstract][Full Text] [Related]
31. Developmental expression of glial fibrillary acidic protein mRNA in the rat brain analyzed by in situ hybridization. Landry CF; Ivy GO; Brown IR J Neurosci Res; 1990 Feb; 25(2):194-203. PubMed ID: 2319628 [TBL] [Abstract][Full Text] [Related]
32. Elevated expression of glucose transporter-1 in hypothalamic ependymal cells not involved in the formation of the brain-cerebrospinal fluid barrier. Garcia MA; Carrasco M; Godoy A; Reinicke K; Montecinos VP; Aguayo LG; Tapia JC; Vera JC; Nualart F J Cell Biochem; 2001; 80(4):491-503. PubMed ID: 11169733 [TBL] [Abstract][Full Text] [Related]
33. Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10. Almolda B; de Labra C; Barrera I; Gruart A; Delgado-Garcia JM; Villacampa N; Vilella A; Hofer MJ; Hidalgo J; Campbell IL; González B; Castellano B Brain Behav Immun; 2015 Mar; 45():80-97. PubMed ID: 25449577 [TBL] [Abstract][Full Text] [Related]
34. Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat. Hidalgo J; Florit S; Giralt M; Ferrer B; Keller C; Pilegaard H Brain Behav Immun; 2010 Jan; 24(1):119-26. PubMed ID: 19748567 [TBL] [Abstract][Full Text] [Related]
35. Induction of metallothionein mRNA and protein in primary murine neuron cultures. Kramer KK; Zoelle JT; Klaassen CD Toxicol Appl Pharmacol; 1996 Nov; 141(1):1-7. PubMed ID: 8917669 [TBL] [Abstract][Full Text] [Related]
36. Metallothionein-1+2 protect the CNS after a focal brain injury. Giralt M; Penkowa M; Lago N; Molinero A; Hidalgo J Exp Neurol; 2002 Jan; 173(1):114-28. PubMed ID: 11771944 [TBL] [Abstract][Full Text] [Related]
37. Modulation of metallothionein-III mRNA content and growth rate of rat C6-glial cells by transfection with human 5-HT1D receptor genes. Amoureux MC; Wurch T; Pauwels PJ Biochem Biophys Res Commun; 1995 Sep; 214(2):639-45. PubMed ID: 7677777 [TBL] [Abstract][Full Text] [Related]
38. Analysis of metallothionein brain gene expression in relation to ethanol preference in mice using cosegregation and gene knockouts. Loney KD; Uddin RK; Singh SM Alcohol Clin Exp Res; 2006 Jan; 30(1):15-25. PubMed ID: 16433728 [TBL] [Abstract][Full Text] [Related]
39. Regulation of metallothionein-I+II levels in specific brain areas and liver in the rat: role of catecholamines. Gasull T; Giralt M; Garcia A; Hidalgo J Glia; 1994 Oct; 12(2):135-43. PubMed ID: 7868187 [TBL] [Abstract][Full Text] [Related]
40. Activation of the complete mouse metallothionein gene locus in the maternal deciduum. Liang L; Fu K; Lee DK; Sobieski RJ; Dalton T; Andrews GK Mol Reprod Dev; 1996 Jan; 43(1):25-37. PubMed ID: 8720110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]